Voices of Biotech
Podcast: MilliporeSigma says education vital to creating unbreakable chain for sustainability
MilliporeSigma discusses the importance of people, education, and the benefits of embracing discomfort to bolster sustainability efforts.
BPI Contributor
May 31, 2019
20 Min View
Date: May 31, 2019
Duration: 20 Min
Sponsored by Abzena
This webcast features: Campbell Bunce, Chief Scientific Officer, Abzena
Developability assessment is based on multiple readouts that capture the fundamental characteristics of successful drug design: specificity, functionality, safety and manufacturability.
Developability assessment can severely reduce the time and expenditure required to take multiple lead candidates through expensive cell line development and manufacturing runs when the molecule has inherent liabilities that will inhibit its progress.
Why do it:
Identify liabilities and risk factors in drug candidates early in the development process
Scope to apply design alterations to fix/reduce liabilities
Select the best drug candidate(s) for development
Reduces risk and expenditure on later costly stages of development: production cell line generation and manufacture
What to expect from it:
Drug candidates ranked across multiple parameters
Establish and implement a plan to adjust drug design early in the process to mitigate risks
Lead candidate identified for manufacture with minimized cost and risk profile
Watch the recorded webcast below.
About the Author(s)
You May Also Like
Upcoming Webcasts
Jun 17 - Jun 20, 2024
Jun 17 - Jun 20, 2024
Our Biopharmaceutical School is the perfect course to gain a well-rounded understanding of the Biopharmaceutical industry. Over three days, you will understand the principle steps in the biopharmaceutical lifecycle, including: raw material selection, up and downstream processes and core technology. Additionally, you will be familiarised with the latest industry trends, including Industry 4.0, and how these are likely to impact the industry’s evolution.
Through a combination of sessions led by experts from the likes of GSK and Pall Biotech, as well as group discussions with your peers, you will learn how to bring a biopharmaceutical drug to market. Each day will be chaired by a different member of the BioProcess International Academy faculty and there will also be time for networking and Q&As with the experts.
Learn More